Congress: 118 · Status: active · Israel/Palestine classification: pro-Israel
Data (JSON) — machine-readable record of this bill (identifiers, sponsor, classification, actions, and the member-by-member vote breakdown).
Official record on Congress.gov — full text, actions, and cosponsor history for HR 8299.
Sponsor: Buchanan, Vern (R-Florida)
The bill directs the Department of Health and Human Services to create a formal program coordinating U.S.-Israel collaboration on medical technology, pharmaceuticals, medical devices, digital health, and biologics manufacturing. The program would facilitate joint research projects, support startup ecosystem development, align regulatory standards between FDA and Israeli health authorities, establish a potential U.S.-Israel Health Care Collaboration Center, and authorize $8 million annually through 2029.
This is a non-binding authorization for medical research and technology-sharing cooperation with Israel, with no restrictions or conditions tied to Israeli government conduct. The bill reflects congressional interest in deepening U.S.-Israel institutional ties in the health sector and establishes a framework for ongoing bilateral coordination.